Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Banyard, Jacqueline ^a,b   Chung, Ivy ^a,b,d   Wilson, Arianne M ^a   Vetter, Guillaume ^c,e   Le Béchec, Antony ^c,f   Bielenberg, Diane R ^a,b   Zetter, Bruce R ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e Prestizia Theradiag group Cap Alpha   (France)

^f Institut Régional Contre le Cancer   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CADHERIN; CELL ADHESION MOLECULE; CYTOKERATIN 18; MICRORNA; MIRN200 MICRORNA, MOUSE; MIRN424 MICRORNA, MOUSE; TUMOR ANTIGEN; TUMOR-ASSOCIATED ANTIGEN GA733; VIMENTIN;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL ADHESION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MOUSE; NUDE MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTIGENS, NEOPLASM; CADHERINS; CELL ADHESION; CELL ADHESION MOLECULES; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KERATIN-18; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; MICRORNAS; OLIGONUCLEOTIDES, ANTISENSE; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; VIMENTIN;

EID: 84889584667     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03151     Document Type: Article

References (57)

1. Gupta, G. P. & Massague, J. Cancer metastasis: Building a framework. Cell 127, 679-695 (2006) (Pubitemid 44781029)
2. Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J Clin Invest 119, 1420-1428 (2009)
3. Tarin, D., Thompson, E. W. & Newgreen, D. F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65, 5996-6000; discussion 6000-5991; (2005) (Pubitemid 40994379)
4. Thompson, E. W., Newgreen, D. F. & Tarin, D. Carcinoma invasion and metastasis: A role for epithelial-mesenchymal transition Cancer Res 65, 5991-5995 discussion 5995 (2005) (Pubitemid 40994377)
5. Garber, K. Epithelial-to-mesenchymal transition is important to metastasis, but questions remain. J Natl Cancer Inst 100, 232-239 (2008)
6. Ledford, H. Cancer theory faces doubts. Nature 472, 273 (2011)
7. Chui, M. H. Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step. Int J Cancer 132, 1487-1495 (2013)
8. Weinberg, R. A. Leaving home early: reexamination of the canonical models of tumor progression. Cancer Cell 14, 283-284 (2008)
9. Brabletz, T. To differentiate or not-routes towards metastasis. Nat Rev Cancer 12, 425-436 (2012)
10. Chaffer, C. L. et al.Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66, 11271-11278 (2006) (Pubitemid 46009956)
11. Chao, Y. L., Shepard, C. R. & Wells, A. Breast carcinoma cells re-express Ecadherin duringmesenchymal to epithelial reverting transition. Mol Cancer 9, 179 (2010)
12. Korpal, M. et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. NatMed 17, 1101-1108 (2011)
13. Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S. & Yang, J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22, 725-736 (2012)
14. Ocana, O. H. et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22, 709-724 (2012)
15. Tse, J. C. & Kalluri, R. Mechanisms of metastasis: Epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem 101, 816-829 (2007) (Pubitemid 47040864)
16. Zhang, J. & Ma, L. MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 31, 653-662 (2012)
17. Bullock, M. D., Sayan, A. E., Packham, G. K. & Mirnezami, A. H. MicroRNAs: Critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression. Biol Cell 104, 3-12 (2012)
18. Siegel, R. et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62, 220-241 (2012)
19. Cheng, L. et al. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol 174, 2181-2185 (2005) (Pubitemid 41611770)
20. Karakiewicz, P. I. & Hutterer, G. C. Predictive models and prostate cancer. Nat Clin Pract Urol 5, 82-92 (2008) (Pubitemid 351248097)
21. Sleeman, J. P. & Thiele, W. Tumor metastasis and the lymphatic vasculature. Int J Cancer 125, 2747-2756 (2009)
22. Wilt, T. J. et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367, 203-213 (2012)
23. Stephenson, R. A. et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 84, 951-957 (1992)
24. Fidler, I. J. The organ microenvironment and cancer metastasis. Differentiation 70, 498-505 (2002) (Pubitemid 36194315)
25. Hanahan, D.&Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011)
26. Sottnik, J. L., Zhang, J., Macoska, J. A. & Keller, E. T. The PCa Tumor Microenvironment. Cancer Microenviron 4, 283-297 (2011)
27. Pettaway, C. A. et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 2, 1627-1636 (1996) (Pubitemid 126447459)
28. Stone, K. R.,Mickey, D. D.,Wunderli, H.,Mickey, G. H. & Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 21, 274-281 (1978) (Pubitemid 8283045)
29. Taube, J. H. et al. Core epithelial-to-mesenchymal transition interactome geneexpression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107, 15449-15454 (2010)
30. Park, S. M., Gaur, A. B., Lengyel, E. & Peter, M. E. ThemiR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907 (2008) (Pubitemid 351482843)
31. Korpal, M., Lee, E. S., Hu, G. & Kang, Y. The miR-200 family inhibits epithelialmesenchymal transition and cancer cell migration by direct targeting of Ecadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283, 14910-14914 (2008)
32. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601 (2008) (Pubitemid 351627379)
33. Hurteau, G. J., Carlson, J. A., Spivack, S. D. & Brock, G. J. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 67, 7972-7976 (2007) (Pubitemid 47395127)
34. Burk, U. et al. Areciprocal repression between ZEB1 and members of themiR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 9, 582-589 (2008) (Pubitemid 351772923)
35. Cochrane, D. R., Spoelstra, N. S., Howe, E. N., Nordeen, S. K. & Richer, J. K. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubuletargeting chemotherapeutic agents. Mol Cancer Ther 8, 1055-1066 (2009)
36. Bindels, S. et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 25, 4975-4985 (2006)
37. Zwaans, B. M. & Bielenberg, D. R. Potential therapeutic strategies for lymphatic metastasis. Microvasc Res 74, 145-158 (2007) (Pubitemid 350051029)
38. Friedl, P. & Gilmour, D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10, 445-457 (2009)
39. Giampieri, S. et al. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11, 1287-1296 (2009)
40. Hager, M. H. et al. DIAPH3 governs the cellular transition to the amoeboid tumour phenotype. EMBO Mol Med 4, 743-760 (2012)
41. Brase, J. C. et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 128, 608-616 (2011)
42. Mitchell, P. S. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105, 10513-10518 (2008)
43. Zeisberg, M. & Neilson, E. G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119, 1429-1437 (2009)
44. Putzke, A. P. et al. Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases. Am J Pathol 179, 400-410 (2011)
45. Chunthapong, J. et al. Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 91, 649-661 (2004)
46. Xu, J. et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 32, 976-987 (2012)
47. Long, X. H. et al. Tumor suppressive microRNA-424 inhibits osteosarcoma cell migration and invasion via targeting fatty acid synthase. Exp Ther Med 5, 1048-1052 (2013)
48. Ghosh, G. et al. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J Clin Invest 120, 4141-4154 (2010)
49. Kim, J. et al. An endothelial apelin-FGF link mediated by miR-424 andmiR-503 is disrupted in pulmonary arterial hypertension. Nat Med 19, 74-82 (2013)
50. Nakashima, T. et al. Down-regulation of mir-424 contributes to the abnormal angiogenesis via MEK1 and cyclin E1 in senile hemangioma: Its implications to therapy. PLoS One 5, e14334 (2010)
51. Chamorro-Jorganes, A. et al. MicroRNA-16 and microRNA-424 regulate cellautonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. Arterioscler Thromb Vasc Biol 31, 2595-2606 (2011)
52. Rosa, A. et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc Natl Acad Sci U S A 104, 19849-19854 (2007)
53. Forrest, A. R. et al. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation. Leukemia 24, 460-466 (2010)
54. Bonci, D. et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14, 1271-1277 (2008)
55. Takeshita, F. et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18, 181-187 (2010)
56. Le Bechec, A. et al. MIR@NT@N: A framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model. BMC Bioinformatics 12, 67 (2011)
57. Fassina, A. et al. Epithelial-mesenchymal transition in malignant mesothelioma. Mod Pathol 25, 86-99 (2012)